Anaerobic growth of Candida albicans does not support biofilm formation under similar conditions used for aerobic biofilm

Current Microbiology

Volumn 51, Issue 2, 2005, Pages 100-104

  Biswas, Swarajit K ^a   Chaffin, W LaJean ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOFILM; CANDIDA ALBICANS; CONTROLLED STUDY; MOUTH CAVITY; NONHUMAN; PH MEASUREMENT; PRIORITY JOURNAL; SOLID; SURFACE PROPERTY; SUSPENSION;

AEROBIOSIS; ANAEROBIOSIS; BACTERIAL ADHESION; BIOFILMS; CANDIDA ALBICANS; CULTURE MEDIA;

CANDIDA ALBICANS; FUNGI;

EID: 23844555572     PISSN: 03438651     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00284-005-4552-3     Document Type: Article

References (21)

1. Andreasen AA, Stier TJ (1953) Anaerobic nutrition of Saccharomyces cerevisiae. I. Ergosterol requirement for growth in a defined medium. J Cell Physiol 41:23-36
2. Andreasen AA, Stier TJ (1954) Anaerobic nutrition of Saccharomyces cerevisiae. II. Unsaturated fatty acid requirement for growth in a defined medium. J Cell Physiol 43:271-281
3. +-inhibited germ tube formation of Candida albicans. Med Mycol 38:363-369
4. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA (2001) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183:5385-5394
5. Chandra J, Mukherjee PK, Leidich SD, Faddoul FF, Hoyer LL, Douglas LJ, Ghannoum MA (2001) Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 80:903-908
6. Douglas LJ (2002) Medical importance of biofilms in Candida infections. Rev Iberoam Micol 19:139-143
7. Dumitru R, Hornby JM, Nickerson KW (2004) Defined anaerobic growth medium for studying Candida albicans basic biology and resistance to eight antifungal drugs. Antimicrob Agents Chemother 48:2350-2354
8. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP (1999) Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29:239-244
9. Guentzel MN, Herrera C (1982) Effects of compromising agents on candidosis in mice with persistent infections initiated in infancy. Infect Immun 35:222-228
10. Kirsop BH (1982) Developments in beer fermentation. Top Enzyme Ferment Biotechnol 6:79-131
11. Mateus C, Crow SA Jr, Ahearn DG (2004) Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole. Antimicrob Agents Chemother 48:3358-3366
12. Odds FC (1988) Candida and candidosis, 2nd ed. London: Bailliere Tindall
13. Pollack JH, Hashimoto T (1987) The role of glucose in the pH regulation of germ-tube formation in Candida albicans. J Gen Microbiol 133:415-424
14. Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL (2001) Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45:2475-2479
15. Ramage G, Vandewalle K, Wickes BL, Lopez-Ribot JL (2001) Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micobiol 18:163-170
16. Reagan DR, Pfaller MA, Hollis RJ, Wenzel RP (1990) Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. J Clin Microbiol 28:2733-2738
17. Rolfe RD, Finegold SM (1979) Purification and characterization of Clostridium difficile toxin. Infect Immun 25:191-201
18. Sanglard D, Ischer F, Parkinson T, Falconer D, Bille J (2003) Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Chemother 47:2404-2412
19. Szawatkowski M, Hamilton-Miller JMT (1978) Anaerobic growth and sensitivity of Candida albicans. Microbios Lett 5:61-66
20. 2 in air. J Med Vet Mycol 25:47-53
21. Wong L, Sissons C, Sissions CH (2001) A comparison of human dental plaque microcosm biofilms grown in an undefined medium and a chemically defined artificial saliva. Arch Oral Biol 46:477-486